Pediatrix Medical Group Inc
MD at a Glance
- Market cap
- $2.3B
- P/E ratio
- 12.7
- Revenue (TTM)
- $2.0B
- Profit margin
- 9.0%
- EPS (TTM)
- $2.18
- 52-week range
- $16 – $28
- Street target
- $26.33
- Next report
- Nov 2, 2026
Headquartered in Sunrise, FL Fiscal year ends December NYSE: MD pediatrix.com
About Pediatrix Medical Group
Pediatrix Medical Group, Inc. (NYSE: MD), operating under the Mednax corporate name, is a provider of physician services focused on women, babies, and children across hospital-based and office-based care settings. The company's specialties include obstetrics, maternal-fetal medicine, neonatology, and multiple pediatric subspecialties. Founded in 1979 as a single neonatology practice, Pediatrix now delivers specialized and often critical care services through approximately 4,300 affiliated physicians and other clinicians. The company invests in research, education, quality improvement, and safety initiatives to support evidence-based clinical care. Pediatrix generates revenue through patient service fees reimbursed by commercial payors, government programs (including Medicaid and Medicare), and through contract and administrative fees from hospital partners. The company pursues growth through acquisitions of physician practices and organic initiatives, and actively manages its practice portfolio. Pediatrix is currently transitioning to a hybrid revenue cycle management model. Updated
Frequently Asked Questions
What does Pediatrix Medical Group do?
Pediatrix Medical Group, Inc. (NYSE: MD), operating under the Mednax corporate name, is a provider of physician services focused on women, babies, and children across hospital-based and office-based care settings.
What is the MD stock price target?
The Wall Street consensus 12-month price target for MD is $26.33.